| Serial Number | 79351356 |
| Word Mark | K |
| Filing Date | Wednesday, July 20, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 2, 2024 |
| Registration Number | 7256771 |
| Registration Date | Tuesday, January 2, 2024 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 17, 2023 |
| Description of Mark | The mark consists of a stylized letter K with the bottom diagonal leg of the letter K annexed at a right angle with another leg of the same length extending up and out towards the right and a small circle positioned to the right center of the letter K. |
| Goods and Services | Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of diabetic macular edema; pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders |
| Goods and Services | Medical and healthcare services relating to ophthalmic diseases and disorders; medical and health care services relating to diabetic macular edema; medical and healthcare services relating to angioedema; medical and healthcare services relating to hereditary angioedema; medical and healthcare services relating to diseases and disorders mediated by the contact activation system; medical and healthcare services relating to plasma kallikrein or factor XIIa mediated diseases or disorders |
| Goods and Services | Medical and surgical instruments and apparatus for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders; drug delivery devices for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders |
| Goods and Services | Drug discovery services relating to ophthalmic diseases and disorders; drug discovery services relating to diabetic macular edema; drug discovery services relating to angioedema; drug discovery services relating to hereditary angioedema; drug discovery services relating to diseases and disorders mediated by the contact activation system; drug discovery services relating to plasma kallikrein or factor XIIa mediated diseases or disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 30, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 30, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 30, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 30, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kalvista Pharmaceuticals Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Kalvista Pharmaceuticals Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Kalvista Pharmaceuticals Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, April 4, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, April 4, 2024 | FINAL DISPOSITION PROCESSED |
| Tuesday, April 2, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, January 2, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, January 2, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 17, 2023 | NOTIFICATION PROCESSED BY IB |
| Tuesday, October 17, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 17, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 27, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, September 27, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, September 27, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, September 13, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 13, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 13, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 13, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, September 7, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, September 7, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, September 7, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, September 7, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, September 7, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, July 10, 2023 | REFUSAL PROCESSED BY IB |
| Thursday, June 15, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, June 15, 2023 | REFUSAL PROCESSED BY MPU |
| Sunday, May 7, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, May 6, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, May 5, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, October 4, 2022 | APPLICATION FILING RECEIPT MAILED |
| Friday, September 30, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 29, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |